Hepatitis B, diagnosed in [**2149**] - last viral load: undetectable [**2154-2-21**] 3.
Hepatitis C, diagnosed in [**2149**] - viral load undetectable in [**12-26**] His hepatitis B surface antibody was positive in the range of 1:450 on [**2154-3-28**].
His last alpha-fetoprotein level was 53.2 with an L3 fraction of 44.1 on [**2154-2-21**].
His last HBV viral load was nondetectable in [**2154-2-21**].
Subcapsular liver fluid collection status post biopsy on [**2153-12-27**] 5.
Recent CT imaging in [**3-27**] demonstrates multiple lung nodules in lungs concerning for recurrence with AFP rising to >60 in [**2-27**].
Recurrent c diff [**2154-2-11**] and [**2153-12-31**]   Social History: He was a bus driver until the diagnosis of his hepatocellular carcinoma.
Physical Exam: VS T 102 upon arrival to MICU and Tm = 105 in ED P = 117, BP = 146/70 RR O2Sat = 100% 3L GENERAL: Diaphoretic but not in acute distress.
Extremities: No C/C/E bilaterally, 2+ radial, DP and PT pulses b/l.
-cranial nerves: II-XII intact   Pertinent Results: [**2154-4-5**] 01:30PM BLOOD WBC-5.4# RBC-4.08* Hgb-12.7* Hct-37.0* MCV-91 MCH-31.0 MCHC-34.1 RDW-14.1 Plt Ct-144* [**2154-4-6**] 05:16AM BLOOD WBC-6.7 RBC-3.81* Hgb-12.1* Hct-33.7* MCV-89 MCH-31.8 MCHC-35.9* RDW-14.3 Plt Ct-118* [**2154-4-7**] 01:22AM BLOOD WBC-3.2*# RBC-2.82*# Hgb-9.1* Hct-24.9*# MCV-89 MCH-32.3* MCHC-36.5* RDW-14.3 Plt Ct-74* [**2154-4-7**] 09:08AM BLOOD WBC-2.5* RBC-3.27* Hgb-10.4* Hct-30.1* MCV-92 MCH-31.8 MCHC-34.5 RDW-13.9 Plt Ct-70* [**2154-4-8**] 04:11AM BLOOD WBC-2.3* RBC-3.15* Hgb-10.0* Hct-28.2* MCV-90 MCH-31.8 MCHC-35.5* RDW-14.2 Plt Ct-79* [**2154-4-9**] 05:07AM BLOOD WBC-3.0* RBC-3.41* Hgb-10.7* Hct-30.1* MCV-88 MCH-31.3 MCHC-35.4* RDW-14.3 Plt Ct-105* [**2154-4-5**] 01:30PM BLOOD Glucose-109* UreaN-11 Creat-1.0 Na-135 K-4.7 Cl-100 HCO3-23 AnGap-17 [**2154-4-5**] 09:30PM BLOOD Glucose-132* Na-135 K-3.7 Cl-103 HCO3-21* AnGap-15 [**2154-4-6**] 05:16AM BLOOD Glucose-112* UreaN-10 Creat-1.1 Na-136 K-3.6 Cl-105 HCO3-21* AnGap-14 [**2154-4-7**] 01:22AM BLOOD Glucose-121* UreaN-10 Creat-0.9 Na-138 K-3.4 Cl-111* HCO3-18* AnGap-12 [**2154-4-7**] 09:08AM BLOOD Glucose-116* UreaN-9 Creat-0.8 Na-140 K-3.6 Cl-113* HCO3-18* AnGap-13 [**2154-4-8**] 04:11AM BLOOD Glucose-97 UreaN-6 Creat-0.7 Na-139 K-3.7 Cl-111* HCO3-20* AnGap-12 [**2154-4-9**] 05:07AM BLOOD Glucose-119* UreaN-6 Creat-0.8 Na-141 K-3.6 Cl-112* HCO3-22 AnGap-11 [**2154-4-5**] 01:30PM BLOOD ALT-40 AST-73* Amylase-73 TotBili-0.6 [**2154-4-5**] 09:30PM BLOOD ALT-36 AST-53* LD(LDH)-274* AlkPhos-72 TotBili-0.9 [**2154-4-6**] 05:16AM BLOOD ALT-35 AST-48* LD(LDH)-273* AlkPhos-68 TotBili-1.1 [**2154-4-7**] 01:22AM BLOOD ALT-32 AST-44* AlkPhos-56 Amylase-70 TotBili-0.7 [**2154-4-7**] 09:08AM BLOOD ALT-31 AST-42* AlkPhos-54 Amylase-71 TotBili-0.5 [**2154-4-8**] 04:11AM BLOOD ALT-28 AST-35 AlkPhos-55 Amylase-67 TotBili-0.4 [**2154-4-9**] 05:07AM BLOOD ALT-26 AST-35 AlkPhos-65 TotBili-0.4  ERCP: 1.The major papilla was located in the second part of the duodenum with an existing plastic stent within.
CT abd/pelvis: 1.
Redemonstration of 1.3-cm left hepatic lesion.
Followup MRI in four to six months from the prior MRI is recommended.
His MMF was held out of concern for malignancy.
Followup Instructions: Provider: [**Name10 (NameIs) **] [**Name8 (MD) 490**], MD, PHD[**MD Number(3) 708**]:[**0-0-**] Date/Time:[**2154-4-18**] 9:30 Provider: [**Name10 (NameIs) **],[**Name11 (NameIs) **] HEMATOLOGY/ONCOLOGY-CC9 Date/Time:[**2154-4-18**] 9:30 Provider: [**Name10 (NameIs) 706**] MRI Phone:[**Telephone/Fax (1) 327**] Date/Time:[**2154-4-19**] 12:00 Provider: [**Name10 (NameIs) **],[**Name11 (NameIs) **] HEPATOLOGY Date/Time:[**2154-5-1**] 8:00                                [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] MD [**MD Number(1) 1379**]
